The CSTL partners with multiple organizations that help us advance and optimize our research battling Castleman Disease.
The CSTL works closely with the CDCN on our shared mission and vision of curing CD. The CDCN drives forward research, connects and supports patients, and connects and supports physicians and researchers worldwide.
We're partnering with CZI to expand the patient-driven, collaborative network approach we've taken for studying Castleman disease to other rare diseases.
Click here to learn more about our partnership: Rare As One
We're partnering with Medidata to analyze large-scale serum proteomic data to gain meaningful clinical insights.
Click here to learn more about our partnership: Medidata Collaboration
The CSTL is a Program of Excellence of the Penn Orphan Disease Center. Our collaboration also aims to improve the research of rare diseases.